3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
3
Vaginal Neoplasms
2
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neuroendocrine Tumors
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Accelerated Phase
1
Gallbladder Neoplasms
1
Blast Crisis
1
Interventions
Cytarabine
23
fludarabine phosphate
9
Daunorubicin
9
Mitoxantrone
8
Busulfan
8
Peripheral Blood Stem Cell Transplantation
6
Methotrexate
6
Idarubicin
6
Gemtuzumab
6
Etoposide
6
Whole-Body Irradiation
5
Filgrastim
5
Cyclophosphamide
5
Clofarabine
5
tipifarnib
4
alvocidib
4
Vorinostat
4
Tacrolimus
4
Cyclosporine
4
Azacitidine
4
Antilymphocyte Serum
4
sargramostim
3
Observation
3
Mycophenolic Acid
3
Flow Cytometry
3
Decitabine
3
Cytogenetic Analysis
3
Bortezomib
3
fludarabine
2
aldesleukin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Erythroblastic, Acute
×
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
×
Clear all
No trials found.